Nasdaq:US$17.48 (+0.04) | HKEX:HK$27.60 (+0.00) | AIM:£2.54 (+0.07)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 13 Jul 2009

Phase II Crohn’s Disease Trial for HMPL-004 Delivers Encouraging Results

1 items
a090713